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Abstract
Background:  The Actinomycete Actinosynnema pretiosum ssp.  auranticum  has commercial
importance due to its production of ansamitocin P-3 (AP-3), a potent antitumor agent. One way to
increase AP-3 production would be to constitutively express selected genes so as to relieve
bottlenecks in the biosynthetic pathway; however, an integrative expression vector for A. pretiosum
is lacking. The aim of this study was to construct a vector for heterologous gene expression in A.
pretiosum.
Results: A series of integrative expression vectors have been made with the following features:
the IS117 transposase from Streptomyces coelicolor, the constitutive ermE* promoter from
Saccharopolyspora erythraea, different ribosome-binding site (RBS) sequences and xylE  as a
translational reporter. Positive E. coli clones and A. pretiosum transconjugants were assayed by
catechol. pAP42, containing an E. coli consensus RBS, and pAP43, containing an asm19 RBS, gave
strong and moderate gene expression, respectively. In addition, an operon construct capable of
multi-gene expression was created. Plasmid integration sites in transconjugants were investigated
and four different sites were observed. Although the most common integration site was within a
putative ORF with sequence similarity to NADH-flavin reductase, AP-3 levels and cell growth of
transconjugants were unaffected.
Conclusion: A set of integrative vectors for constitutive gene expression in A. pretiosum has been
constructed. Gene translation is easily determined by colorimetric assay on an agar plate. The
vectors are suitable for studies relating to AP-3 biosynthesis as they do not affect AP-3 production.
Background
Actinosynnema pretiosum is a commercially important
organism due to its ability to produce ansamitocin P-3
(AP-3), a potent anti-tumor agent [1,2]. The cytotoxicity
of ansamitocin has prompted its use as a toxic "warhead"
in immuno-toxin conjugates [3]. Several of these conju-
gates are currently in late-phase clinical trials as therapeu-
tic agents against solid tumors [4]. Thus, there is interest
in generating strains of A. pretiosum that produce greater
concentrations of AP-3 to meet increasing industrial
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demands, particularly as the yield from wild type A. preti-
osum is low (~18 – 83 mg/l) [2,5]. Previously, a random
mutagenesis approach [6] has been used to generate
strains which produce 5- to 10-fold more AP-3 than the
parental strain. Recently, deletion of a putative transcrip-
tional repressor, asm2, has also been reported to increase
AP-3 yield [7].
One method to improve the productivity of A. pretiosum
would be to alter the regulation of ansamitocin biosyn-
thesis through genetic manipulation of selected genes.
The AP-3 biosynthetic genes, identified through compari-
sons with the Amycolatopsis mediterranei rifamycin biosyn-
thetic gene clusters, and gene expression in Streptomyces
lividans [8] and S. coelicolor [9], revealed the lack of a rifH
homologue in A. pretiosum [9]. The rifH gene encodes an
aminoDAHP synthase in A. mediterranei and is involved in
the synthesis of aminoDAHP required for the AP-3 precur-
sor, 3-amino-5-hydroxy-benzoic acid (AHBA). Addition
of AHBA has been shown to increase AP-3 production
[10]. Although DAHP synthase from the shikimate path-
way in A. pretiosum may supply the AHBA pathway [9], it
is not dedicated to aminoDAHP synthesis. Based on these
reports, we hypothesized that a metabolic bottleneck in
the synthesis of aminoDAHP was the limiting factor in
AP-3 biosynthesis and sought to relieve this bottleneck
through heterologous expression of rifH, thus providing
an aminoDAHP synthase for A. pretiosum.
We report the construction of a series of novel expression
vectors that allow stable integration of target genes into
the A. pretiosum genome. The vectors have components
from pSET152 [11], the IS117 transposable element [12]
and the ermE* promoter [13], all of which have never pre-
viously been used in A. pretiosum. We have shown func-
tionality of the vectors in E. coli, as the cloning host, and
in A. pretiosum, as the transconjugant. We also validated
plasmid constitutive expression, reporter function and
integration preference, which did not alter host cell den-
sity or AP-3 levels. Finally, we demonstrate the vector's
usefulness in heterologous expression of rifH in A. pretio-
sum and report its effects on AP-3 production.
Results
Conjugable and integrative pAP expression plasmids in A. 
pretiosum
IS117 is a well studied transposable element capable of
integrating into several Streptomyces species [14,15] and
into Mycobacterium smegmatis [16]. Plasmids containing
IS117 had previously been derived from the mini-circle
version [16,17]. In this study, IS117 was derived from a
linearized and amplified copy in the Streptomyces coelicolor
A3(2) chromosome and modified at the ends for integra-
tion into the chromosome of A. pretiosum (Figure 1). Plas-
mid containing IS117 with unmodified ends did not
result in A. pretiosum transconjugants. By moving the attM
(reverse complement) sequence, CTA, and the 15 bases
upstream of it from the 3' end (downstream of orf2) to the
5' end (upstream of orf1), chromosomal integration at the
attM site was restored. In this regard, consensus sequences
of up to 19 nucleotides flanking attM have been identified
in the genomes of S. lividans [14] and M. smegmatis [16],
suggesting a role in alignment of the integration site.
Transconjugants of pAP40 were apramycin resistant and
circular plasmids were not detected in a chromosomal
DNA preparation (not shown), which was expected, as the
plasmid lacked a Streptomyces replicon.
The ermE*p is a strong promoter that has been used in
Streptomyces for protein expression [18,19] and modulat-
ing secondary metabolites production [20-22], making it
useful for this study. Three different RBS sequences were
tested for efficiency: the unusual RBS sequence of ermE
(pAP41) [13], an E. coli consensus RBS sequence (pAP42)
[17], and a putative RBS sequence found upstream of the
A. pretiosum gene, asm19 (pAP43) [9] (Figure 1). E. coli
clones and transconjugants of pAP41, 42, and 43 were
tested for metapyrocatachase activity, encoded by xylE,
with catechol. Catechol positive colonies were observed
strongly in E. coli clones of pAP42 and mildly in pAP43
clones while pAP41 clones were negative (Figure 2a). A.
pretiosum transconjugants of pAP42 turned bright yellow,
while transconjugants of pAP43 and pAP41 turned
slightly yellow and did not change color, respectively (Fig-
ure 2b). This indicated the E. coli RBS sequence was the
most robust, and that the ermE* promoter was functional
in A. pretiosum. In addition, xylE was a suitable transla-
tional reporter in A. pretiosum.
To apply the reporter gene in an expression system, two
versions of a translational reporter vector were con-
structed. Transconjugants of pAP47 (xylE and rifH fusion)
did not result in catechol positive colonies while
transconjugants of pAP50 (xylE and rifH operon; Figure 1)
were catechol positive and their activities were compara-
ble to transconjugants of pAP42 (Figure 2b).
Constitutive expression of rifH in A. pretiosum
To determine whether the ermE* promoter enabled con-
stitutive expression of rifH  in  A. pretiosum, a clone of
pAP50 was grown in shake-flasks and cells were harvested
over 9 days. Quantitation of rifH mRNA was normalized
against 16S rRNA and calculated relative to the first har-
vest point (day 2). The amount of rifH mRNA on day 4, 7
and 9 did not change significantly (p = 0.16, by one-way
ANOVA) (Figure 3).BMC Biotechnology 2007, 7:72 http://www.biomedcentral.com/1472-6750/7/72
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Integration sites, sequences and stability of pAP40, pAP42 
and pAP50 in A. pretiosum
It was important to determine the site of integration of the
transconjugants to ensure the integrative vector was not
affecting essential genes or genes involved in secondary
metabolite production, and subsequently growth or AP-3
production. IS117 transposition integration has not been
studied in A. pretiosum. Integration frequency was deter-
mined by Southern hybridization of genomic DNA from
12 transconjugants to an IS117 probe (Figure 4). No sig-
nal was observed from wild type A. pretiosum (not shown),
while a single integration event at a specific site was
observed in each transconjugant. Four specific integration
sites (A, B, C and D) were found from sampling 12
transconjugants. The most common was A (9 of 12) while
B, C and D each occurred once (Figure 4). The sequences
of integrated plasmids and chromosomal junctions were
determined by plasmid rescue, which allowed the design
of site A, B, C and D specific PCR primers (Table 1) and
amplification of the chromosomal integration sites. Com-
parison of the IS117 integration sites in A. pretiosum to
those in M. smegmatis revealed consensus sequences for A.
pretiosum sites A, C and D and M. smegmatis site A, and A.
pretiosum site B and M. smegmatis sites B and C (Figure 5).
Sequence analysis revealed that A. pretiosum site A was
within an ORF with homology to a putative NADH-flavin
reductase of Nocardia farcinica IFM 10152 (gi 54024270,
E-value 1e-13, similarity in 70 of 192 aa). Sites B, C and D
were in intergenic regions, upstream of a putative integral
membrane protein of Thermobifida fusca YX, downstream
of a glutamyl-tRNA synthetase of Nocardia farcinica IFM
10152, and upstream of a putative ATP-dependent RNA
helicase of N. farcinica IFM 10152, respectively. The pAP
plasmids did not cause target site duplication upon inte-
Construction of A. pretiosum vectors Figure 1
Construction of A. pretiosum vectors. Maps of plasmids with relevant features and single restriction sites are shown. Site 
directed mutagenesis of IS117 for a functional attM is indicated in pAP3. pAP41, pAP42 and pAP43 consist of xylE with RBS 
sequences from S. erythraea, E. coli and A. pretiosum genes, respectively, although only the E. coli RBS sequence is indicated. The 
aac(3)IV gene encoding apramycin resistance is represented by aprR.
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gration. PCR amplification of chromosomal and plasmid
junctions was used to detect tandem insertions, which
would result in amplicons of 272 bp and > 6 kb, or dele-
tions, which would not result in an amplicon. Tandem
insertions or deletions were not detected in the transcon-
jugants by Southern hybridization or PCR (not shown).
Stability of plasmids integrated into sites A, B, C and D of
A. pretiosum was determined. After 50 duplications under
non-selective conditions, cultures representing each of the
integration sites had less than 1% plasmid loss.
AP-3 production of transconjugants
Since the most common site of plasmid integration was
within a putative ORF, the effect of integration on AP-3
production was of interest. Mean AP-3 yields from WT in
YMG obtained on ten different occasions were 13.3 ± 5.6
mg/l for day 7 and 15.3 ± 5.1 mg/l for day 9. Transconju-
gants 1 to 4 of pAP40, pAP42 and pAP50 having either site
A, B, C or D plasmid integrations were assayed for AP-3
production in YMG. For pAP40 transconjugants, site A
mutants did not affect AP-3 yield over 9 days, but the site
D mutant had lower AP-3 yields, particularly on day 7
(Figure 6a). All pAP42 and pAP50 transconjugants
expressing xylE and rifH, respectively, had similar AP-3
yield to the WT at the end of the fermentation period (Fig-
Integration sites in A. pretiosum transconjugants of pAP40,  pAP42 and pAP50 Figure 4
Integration sites in A. pretiosum transconjugants of pAP40, 
pAP42 and pAP50. Total DNA from apramycin resistant 
transconjugants were digested with ApaI and hybridized to a 
DIG-labeled IS117 probe. Unintegrated pAP40, pAP42 and 
pAP50 from E. coli were similarly digested and included as 
controls. Patterns of hybridized bands of each sample repre-
senting an integration site was arbitrarily labeled A, B, C and 
D. Site A consisted of an unchanged 3.5 kb band from the 
right arm of the integrated plasmid, and a variable left arm, 
dependent on the cloned gene of interest. Control plasmids 
have the same molecular weight as the left arm of its corre-
sponding integrated plasmids because of an ApaI site on the 
genome, and not because of unintegrated plasmids in the 
total DNA extract. Transconjugants 1, 2, 3 and 4 of pAP40, 
pAP42 and pAP50 were subsequently tested for AP3 produc-
tion.
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Catechol assay for xylE expression Figure 2
Catechol assay for xylE expression. (a) E. coli clones express-
ing xylE with an E. coli consensus RBS (pAP42), ermE RBS 
(pAP41) and asm19 RBS (pAP43). (b) A. pretiosum transconju-
gants of the same plasmids responded to catechol as in (a). 
Also shown are the operon construct (pAP50) and the fusion 
construct (pAP47).
WT pAP42
pAP41 pAP43
pAP47 pAP50
(b) (a)
pAP41
pAP42
pAP43 Constitutive expression of rifH Figure 3
Constitutive expression of rifH. A clone of pAP50 grown in 
YMG shake-flasks in triplicate was harvested over 9 days and 
rifH mRNA abundance relative to day 2 was determined by 
qRT-PCR.BMC Biotechnology 2007, 7:72 http://www.biomedcentral.com/1472-6750/7/72
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ure 6b &6c). Packed cell volume of transconjugants, rep-
resenting cell growth, was also measured for each AP-3
assay and found to be equivalent to that of WT (not
shown).
Discussion
An important factor in expression vectors is a suitable
RBS; failure of pAP41 for xylE expression in E. coli was
likely due to host ribosome and RBS incompatibility. The
vector with an E. coli consensus RBS sequence (pAP42)
resulted in the strongest expression of xylE, while the puta-
tive RBS sequence of A. pretiosum asm19 (pAP43) resulted
in weaker expression. Hence, while pAP42 is useful for
strong constitutive expression of target genes, pAP43 may
be used if moderate expression is required. To confirm
translation of the gene of interest, two versions of a trans-
lational reporter vector were made. The pAP47 rifH-xylE
fusion construct (not shown) did not produce a func-
tional metapyrocatachase, perhaps due to steric hindrance
of the fused protein or the lack of appropriate transla-
tional signals for xylE, while the pAP50 rifH-xylE operon
construct with an RBS sequence dedicated to the reporter
gene worked well.
Table 1: Primers used in this study.
Primer Sequence (5' – 3')
Vector construction
IS117-KpnI TGACTGGTACCGGAGTCGGGGATGTTCTTGTTC*
IS117-NheI TGACTGCTAGCGTACCGGTGCCCCGATAGAC
ermE-XbaI/KpnI AAAATCTAGAGGTACCAGCCCGACCCGAGCA
ermE-BamHI/EcoRV AAAAGATATCGGATCCACCAACCGGCACGA
xylE-F4Bam CGCGGATCCAGCGATGAACAAAGGTGTAATGCGACC
xylE-FEBam CGCGGATCCAAGCTAACGTAAGGAGGAAAAACATATGAACAAAGGTGTAATGCGACCGGGCCAT
xylE-FABam CGAGGATCCTCCCCACAGACAGGGAGCCCAGCATATGAACAAAGGTGTAATGCGACCGGGCCAT
xylE-REcoRI GCGGAATTCTCAGGTCAGCACGGTC
rifH-FNdeI CGCATACATATGGTGAAGCGGCAGCCGGACTTCG
rifH-RASE CGCGAATTCACTAGTCCTAGGCTAGCGCAGCATCTTCGCGATCG
xylE-FSpeI AATACTAGTATGAACAAAGGTGTAATGCGACCGGGCCAT
xylE-FRBSSpeI CGCAATACTAGTAAGCTAACGTAAGGAGGAAAAACATATGAACAAAGGTGTAATGCGACCGGGCCAT
qPCR
rifH-668F AGATCTACGTCAGCCACGAAATG
rifH-788R TCGCCGATCCACAGGAA
16S-F CAGAAGAAGCACCGGCTAAC
16S-R TTAAGCCCCAAGTTTTCACG
Southern hybridization
IS117-F CTGAACTCACCGCGACGTATCG
IS117-R GCTAGCGTACCGGTGCCCCG
Plasmid rescue and sequencing
intseq1 CCGTTTGGCCTCCGACTAAC
intseq2 GCTCTATCGGGAGGCCTCAC
attM5'1 GGAGCAGACGCTCGTCCGGG
siteA-F GTCGTGGTCACCAGGCGGAC
siteA-R ACCGCCTTCGTCCGTGCCAG
siteB-F GATCTGTGTTCGCGGAGAGC
siteB-R ACAAGGGCGTCAGCGAGGAA
siteC-F GGTGTCCTCGATGCGGAAGA
siteC-R AAGTCCCCGTGCTTCTCCAG
siteD-F GACCCCCTCCGCGAACTGGT
siteD-R GGCCTGCGAGGTTTGTGCGC
*Restriction sites are underlined
Alignment of IS117 integration sites in A. pretiosum and M.  smegmatis Figure 5
Alignment of IS117 integration sites in A. pretiosum and M. 
smegmatis. Bold letters indicate cross over point and capital 
letters indicate identical bases in all compared sequences.
Site A AACCCGCTGTGGCTCAAGGGGAAACGCGGCCCCGCC
Site C GGCCGGAACCCGGTCAAGGGGGATACGCTCACCCGG
Site D CGTGCGCCGGGCGTCAAGGGGAAACTGTACCCGGTG
M. smeg(A) CGTGCCGTCAGTGTCAAGGTGGAAACGAGCAGATCT
Consensus cgtgcgctg-gggTCAAGGgGgAaccg-gCcccgcg
Site B AAACCCCGGCCCAATAGGGTCGGAGCAAGAAAGCA
M. smeg(B) GCCTGGCACGCCGATAGTGGTCGGGCGATCCGGCA
M. smeg(C) TCCCCGCCAGCCGATAGGTTGGACGGGTGGCACTT
Consensus -ccccgC--gCCgATAGggt-gg-Gcgag-cagaaBMC Biotechnology 2007, 7:72 http://www.biomedcentral.com/1472-6750/7/72
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For the purposes of this study, it was important that the
integrative plasmid did not affect host AP-3 production or
bacterial growth. Hence, plasmid integration sites and
their effect on AP-3 levels were determined. Plasmid inte-
gration into site A was most common, while sites B, C and
D occurred once in each set of transconjugants containing
either pAP40, pAP42 or pAP50. Since only four transcon-
jugants of each set were screened, it is unlikely these sec-
ondary sites are plasmid-dependent. Comparison of A.
pretiosum integration sites with those of M. smegmatis and
hence S. lividans revealed GC-rich consensus recognition
sequences flanking the attM that are broadly categorized
into two groups, consisting of either AG or TAG as the
cross-over sequence.
Integration of a plasmid into site A may have inactivated
a putative ORF region, however unchanged AP-3 levels
and packed cell volume in mutants indicate that a prefer-
ence for site A did not interfere with AP-3 biosynthesis or
cell growth. Similarly, integration into secondary sites of
B, C and D did not markedly affect AP-3 production after
9 days. Although rifH mutants also had unchanged AP-3
levels, suggesting the presence of aminoDAHP synthase
does not have any effect on AP-3 biosynthesis, more work
needs to be done to assess the activity of RifH in transcon-
jugants, and to optimize substrates in the growth media,
to draw any final conclusions on the effect of RifH modu-
lation on AP-3.
Conclusion
We have constructed a series of useful genetic tools for the
industrially valuable bacterium A. pretiosum. Stable main-
tenance, translational reporter function in E. coli and A.
pretiosum, strong and moderate constitutive gene expres-
sion and lack of any effect on AP-3 production and bacte-
rial growth are all desirable features of the pAP42/43/50
vectors.
Methods
Bacterial strains, plasmids and growth conditions
Media was prepared from DIFCO stocks and antibiotics
were purchased from Sigma, unless otherwise stated. A.
pretiosum and E. coli strains used in this study are listed in
Table 2. A. pretiosum spore stocks were prepared as previ-
ously described [23], and working stocks were either sub-
cultured from spore stocks or a single colony grown on
YMG agar (4 g/l yeast extract, 10 g/l malt extract, 4 g/l glu-
cose, 20 g/l agar, pH 7.2) or MYM agar (4 g/l yeast extract,
4 g/l maltose, 10 g/l malt extract, 20 g/l agar) at 26°C for
2–3 days, and inoculated in YMG or VM (5 g/l meat
extract, 5/L g peptone, 5 g/l yeast extract, 2.5 g/l enzyme
hydrolysate of casein, 20 g/l glucose, 1.5 g/l NaCl) [24]. A.
pretiosum mutants containing the integrative vector were
grown in media supplemented with apramycin (50 μg/
Table 2: Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristic Purpose Reference/Source
Amycolatopsis mediterranei Rifamycin producer Amplification of rifH ATCC
S. coelicolor A(3)2 IS117 transposable elements Amplification of IS117 ATCC
A. pretiosum 31565 AHBA biosynthesis gene cluster Amplification of asm19 RBS, conjugation ATCC
E. coli
ET12567/pUZ8002 Methylation-deficient host with non-transmissible helper 
plasmid
Conjugation host [25]
Plasmids
pKS1 aprR, ori Vector backbone This study
pXE3 xylE Amplification of xylE [25]
pAP40 ermE*p, IS117, aac(3)IV Assessment of IS117 This study
pAP41 Derived from pAP40, ermE RBS, xylE Assessment of RBS This study
pAP42 Derived from pAP40, E. coli RBS, xylE Assessment of RBS This study
pAP43 Derived from pAP40, putative asm19 RBS, xylE Assessment of RBS This study
pAP44 Derived from pAP42, E. coli RBS, rifH Construction of translational reporter This study
pAP47 Derived from pAP44, E. coli RBS, rifH-xylE fusion Assessment of translational reporter This study
pAP50 Derived from pAP44, E. coli RBS, rifH-xylE operon 
construct
Assessment of translational reporter This study
AP-3 production of A. pretiosum transconjugants in YMG in  shake flasks Figure 6
AP-3 production of A. pretiosum transconjugants in YMG in 
shake flasks. AP-3 concentration was measured over 9 days. 
(a) Transconjugants 1 (■), 2 (▲), 3 (▼) and 4 () of pAP40 
compared to WT (❍). (b) Transconjugant 1 (■), 2 (▲), 3 (▼) 
and 4 () of pAP42 expressing xylE, compared to WT (❍). 
(c) Transconjugant 1 (■), 2 (▲), 3 (▼) and 4 () of pAP50 
expressing rifH, compared to WT (❍).
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ml). E. coli JM109, XL1 Blue and XL10 Gold transformants
were cultured in LB medium at 37°C supplemented with
apramycin (50 μg/ml). ET12567/pUZ8002 transformants
was maintained in chloramphenicol (25 μg/ml), kanamy-
cin (25 μg/ml) and apramycin (50 μg/ml).
Construction of pAP plasmids
Construction of the pAP plasmids are summarized in Fig-
ure 1. The plasmid pKS1, derived from pSET152 by diges-
tion with SphI and HindIII and treated with Klenow before
ligation, consisted of the apramycin resistance gene
(aac(3)IV) and oriT but not the ϕC31 integrase and
attachment site. IS117 was amplified from an integrated
linear copy in the S. coelicolor A3(2) genomic DNA using
primers IS117-KpnI and IS117-NheI (Table 1). The IS117
PCR product, consisting of orf1, 2 and 3, was digested
with KpnI and NheI and cloned into similar ends in a
modified pKS1 with a KpnI site (pKS1m). IS117 was mod-
ified to obtain a functional attM firstly by mutation of
CTA to CCC downstream of orf2, and secondly by insert-
ing AGCCCCCTGAGATGT upstream of CTA at the 5' end
of orf1 by site-directed mutagenesis, resulting in pAP3.
The ermE* promoter was amplified from pIJ4090 [23]
using primers ermE-XbaI/KpnI and ermE-BamHI/EcoRV
(Table 1) digested with XbaI and EcoRV and cloned into
pAP3 at similar sites to create pAP40.
The reporter gene xylE with different types of RBS was
amplified from pXE3 [25] with forward primers specifying
an RBS from either the ermE* promoter [13] (xylE-
F4Bam),  E. coli genes [17] (xylE-FEBam) or asm19  (gi
21449342) of A. pretiosum.(xylE-FABam), and a reverse
primer (xylE-REcoRI). The different xylE  PCR products
were digested with BamHI and EcoRI and cloned into
pAP40 with similar ends to produce pAP41, 42 and 43
having the ermE RBS, E. coli consensus RBS and asm 19
RBS, respectively, upstream of xylE. Clones of pAP41, 42
and 43 were used in catechol assays to determine func-
tionality of RBS.
rifH (gi 41581793) was amplified from the A. mediterranei
genome with primers rifH-FNdeI and rifH-RASE. The xylE
gene was excised from pAP42 at NdeI and EcoRI to allow
cloning of the rifH PCR product, which was digested with
the same restriction enzymes. This resulted in plasmid
pAP44 containing an E. coli RBS upstream of rifH. Trans-
lation of rifH was determined by creating a xylE fusion and
an operon construct of rifH  and  xylE. For the fusion
recombinant, xylE was amplified from pXE3 with xylE-
FSpeI and xylE-REcoRI. The PCR product was digested
with SpeI and EcoRI and cloned into pAP44 with similar
ends. The rifH stop codon was then removed to enable
translational read through to xylE (pAP47, not shown).
For the operon construct, xylE was amplified with a for-
ward primer containing an E. coli RBS (xylE-FRBSSpeI)
and xylE-REcoRI. The PCR product was digested with SpeI
and EcoRI and cloned into pAP44 with similar ends to
result in pAP50. Clones of pAP50 were examined for con-
stitutive expression of rifH by qRT-PCR and AP-3 produc-
tion in YMG.
Transformation and conjugation
Transformation of E. coli was performed by electropora-
tion using a Gene Pulser (Bio-Rad) as recommended by
the manufacturer. Conjugation between ET12567/
pUZ8002 and A. pretiosum was as described previously
[23]. The integrative vectors were transformed into
ET12567/pUZ8002 and selected with apramycin on LB
agar plates. Selected transformant colonies were grown in
LB medium supplemented with kanamycin (25 μg/ml),
chloramphenicol (25 μg/ml) and apramycin (50 μg/ml)
at 37°C for 20 hours. A 1/50 dilution of the E. coli was
made and grown for 4–5 hours at 37°C to an OD600 of
0.4–0.6. The cells were harvested, washed twice with
equal volumes of LB and resuspended in 0.1× original vol-
ume.  A. pretiosum spores (~108) in 2 × YT were heat-
shocked at 50°C for 10 min, then mixed with the E. coli
suspension by swirling. The mixture was plated on man-
nitol soy agar (MS)+10 mM MgCl2 and incubated at 37°C
for 16 h. The plates were overlaid with 4 ml nutrient soft
agar (0.5% w/v) supplemented with nalidixic acid (120
μg/ml) and apramycin (60 μg/ml), and incubated at 26°C
for 5–7 days. Transconjugants were picked and transferred
to fresh YMG plates supplemented with apramycin (50
μg/ml) and nalidixic acid (25 μg/ml). Spore stocks were
subsequently prepared from the single colonies.
Plasmid stability of transconjugants
A. pretiosum transconjugants of pAP40, pAP42 and pAP50,
representing plasmids integrated at sites A, B, C and D
were tested for plasmid stability [26]. A single colony
from MYM with apramycin (50 μg/ml) was inoculated
into VM (80 ml) and grown at 26°C at 180 rpm for three
days. An aliquot of the culture was appropriately diluted
and plated onto MYM, while the remaining culture was
grown in VM at 26°C with shaking. Colonies (200 cfu)
from the day three MYM plate were transferred to MYM
with apramycin (50 μg/ml) to obtain a ratio of resistant
cells to total cells. After propagating the transconjugant
culture for approximately 50 duplications in VM, the ratio
of apramycin resistant cells to total cells was determined
as before, and plasmid loss was also calculated.
Plasmid rescue
To determine the site of vector integration in transconju-
gants, plasmid rescue was carried out with AscI, which is a
non-cutter for the pAP plasmids. Genomic DNA (1 μg)
with integrated plasmid was digested with AscI and ligated
with T4 DNA ligase (NEB) at 16°C for overnight. The liga-
tion reaction was electroporated with E. coli JM109 cellsBMC Biotechnology 2007, 7:72 http://www.biomedcentral.com/1472-6750/7/72
Page 8 of 9
(page number not for citation purposes)
and transformants were selected on LB agar with apramy-
cin (50 μg/ml). Plasmid DNA was extracted from ran-
domly selected transformants and sequenced with
primers intseq1 and attM5'1 for the right hand plasmid-
chromosome junction, and intseq2 for the left hand junc-
tion (Table 1). Primers specific for the bacterial chromo-
some to the left and right of each integration site (siteA-F,
siteA-R; siteB-F, siteB-R; siteC-F, siteC-R; siteD-F, siteD-R;
Table 1) were used to determine sequences flanking the
integrated plasmid, as well as the integration site of the
wild type genome. Sequence analyses were carried out by
BLASTN and BLASTX.
Nucleic acid extractions
Plasmid DNA extractions were carried out using Qiaprep
Spin Miniprep kit (Qiagen) according to manufacturer's
specifications, while genomic DNA extractions were car-
ried out as previously described [23]. A three day culture
of A. pretiosum in 30 ml VM was washed twice in 10.3%
(w/v) sucrose, treated with lysozyme (1 mg/ml), protein-
ase K (560 μg/ml), SDS (1% v/v) and RNase A (100 μg/
ml). The lysate was washed three times with equal vol-
umes of phenol: chloroform: isoamyl alcohol (Sigma)
and once in an equal volume of chloroform. DNA was
precipitated in 2 M NaCl and 0.6 × isopropanol, washed
twice in 70% (v/v) ethanol, air-dried and dissolved in 10
mM Tris-Cl (pH 8).
Total RNA extraction of A. pretiosum grown in YMG broth
harvested at days 2, 3, 4, 7, 8 and 9 was carried out using
the RiboPure™-Bacteria Kit (Ambion), with the following
modifications. Cultures (7–10 ml) were pelleted and
stored at -80°C until extracted. Cell pellets were resus-
pended in 0.5 × original volume of DEPC water (0.1%, v/
v), freeze-thawed five times in liquid nitrogen and at
55°C, then treated with lysozyme (3.5 mg/ml) at 37°C
for 20 min. Cells were pelleted, resuspended in 350 μl of
RNAwiz, vortexed with zirconia beads for 15 mins before
continuing with the manufacturer's protocol. RNA was
treated with DNase I, electrophoresed in a 1% TAE agar-
ose gel and quantified spectrophotometrically.
Quantitative RT-PCR (qRT-PCR) and sequencing
RNA (1 μg) from three biological replicates was converted
to cDNA using random hexamers and the iScript cDNA
Synthesis kit (Bio-Rad) in a 20 μl reaction. Subsequently,
5 μl of cDNA was used for rifH amplification. For 16S
rRNA amplification, cDNA was diluted 106-fold and 5 μl
was used for quantitative PCR (qPCR). Amplification was
carried out in an ABI Prism 7000 sequence detector where
each amplification reaction contained 12.5 μl of iTaq
SYBR Green Supermix with Rox (Bio-Rad) and 300 nM
each of forward and reverse primers in a 25 μl reaction.
RNA from three biological replicates was used and qPCR
of each cDNA sample was carried out in triplicate. Primers
were designed by Primer Express (Applied Biosystems)
and are as follows: rifH-688F and rifH-788R for the target
gene rifH and 16S-F and 16S-R for the reference gene 16S
rRNA (Table 1). The cycling conditions were 3 min at
95°C, followed by 45 cycles of 15 s at 95°C and 45 s at
58°C. Efficiencies of both primer pairs were found to be
similar, hence, data was analyzed by the 2-ΔΔCT method
[27]. Sequencing was carried out in an ABI Prism 3100
Genetic Analyzer with Big-Dye chemistry.
Southern hybridization
The frequency and site of vector integration in A. pretiosum
transconjugants were determined by Southern hybridiza-
tion. Genomic DNA (4–6 μg) digested with ApaI was
hybridized with DIG-labeled IS117 probe (25 ng/ml)
using the DIG-labeling and detection starter kit (Roche)
[28]. DIG-labeled probe was derived from 1 μg of IS117
amplified from pAP40 with primers IS117-F and IS117-R
(Table 1). Hybridization was carried out at 40°C and
stringency washes were performed in 0.1 × SSC at 65°C.
Catechol assay
Catechol assay was carried out as previously described
with modifications [25]. Streaks were made from single
colonies of the various E. coli transformants onto LB plates
or A. pretiosum transconjugants onto YMG plates contain-
ing 50 μg/ml apramycin. After one (for E. coli) or two (for
A. pretiosum) days, 0.5 M aqueous catechol (Sigma) was
sprayed onto the surface of the plates containing the col-
onies and incubated in the dark at 28°C for 40 min. Pos-
itive xylE expression was seen as a yellow halo around
bacterial streaks.
Extraction and quantification of AP-3
A single colony of either mutant or wild type A. pretiosum
from a working stock plate was subcultured into 10 ml of
YMG with or without apramycin, respectively. The culture
was incubated for 9 days at 26°C with shaking, and aliq-
uots were removed on days 4, 7 and 9 for AP-3 measure-
ment as follows:1 ml was centrifuged at 3270 × g for 15
min and 400 μl of supernatant was mixed with 7.6 ml of
ethyl acetate (Merck) for 1 min by vortexing and centri-
fuged as above at 4°C, while the cell pellet (packed cell
volume) was weighed and noted. The organic phase of the
supernatant mixture was transferred to a fresh tube, evap-
orated in a nitrogen sample concentrator (Techne) and
the desiccated material was resuspended in 200 μl of a
60%/40% (v/v) solution of solvent A (0.1% formic acid
(Merck) in high purity water) and solvent B (0.1% formic
acid in methanol). The sample was eluted at 0.8 ml/min
in a Shimadzu chromatographer with a Hypurity C18 col-
umn (Thermo) with the following gradient pattern: 45%
solvent B for 10 min, 45–70% solvent B for 20 min, 80%
solvent B for 5 min and 45% solvent B for 20 min. The
concentration of AP-3 in the sample was determined byBMC Biotechnology 2007, 7:72 http://www.biomedcentral.com/1472-6750/7/72
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peak comparison with an AP-3 standard (Calbiochem) of
known concentration.
Statistical analysis
Statistical significance was determined by one-way analy-
sis of variance (ANOVA) test performed using Microsoft
Excel. A p-value < 0.05 was considered significant.
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